RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SARZI PUTTINI P
Collezione AOU Città della Salute di Torino

Items : 6

Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2024 Jan;42(1):104-114. doi: 10.55563/clinexprheumatol/q38lu0. Epub 2023 Aug 30.

2024
AOU Città della Salute di Torino

Santo L; Salaffi F; Rossini M; Parisi S; Iannone F; Iagnocco A; Guiducci S; Gremese E; Govoni M; Gorla R; Gerli R; Frediani B; Foti R; Chimenti MS; Carletto A; Corrado A; Conti F; Caporali R; Cauli A; Bugatti S; Atzeni F; Lorenzin M; Cozzi G; Doria A; Collesei A; Scagnellato L; Sarzi Puttini P; Sebastiani M; Semerano A; et alii...

Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study. in BMC rheumatology / BMC Rheumatol. 2022 Sep 12;6(1):57. doi: 10.1186/s41927-022-00284-w.

2022
ASL Città di Torino
AOU Città della Salute di Torino

De Vita S; Conti F; Sarzi Puttini PC; Perricone R; Tirri E; Mazzone A; Guggino G; Grembiale RD; Grassi W; Viapiana O; Raffeiner B; Marchesoni A; Limonta M; Foti R; Iannone F; Del Medico P; Lomater C; Fusaro E; Pagano Mariano G; Frassi M; Colombo D; Ori A; Simoni L; Fiocchi M; Orsenigo R; Zagni E;

A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study. in BMC health services research / BMC Health Serv Res. 2022 Dec 16;22(1):1537. doi: 10.1186/s12913-022-08954-8.

2022
ASL Città di Torino
AOU Città della Salute di Torino

Conti F; De Vita S; Sarzi Puttini PC; Perricone R; Tirri E; Mazzone A; Guggino G; Grembiale RD; Grassi W; Viapiana O; Raffeiner B; Marchesoni A; Limonta M; Foti R; Iannone F; Del Medico P; Lomater C; Fusaro E; Mariano GP; Frassi M; Zagni E; Zullo A; Simoni L; Fiocchi M; Orsenigo R; Colombo D;

Early Spondyloarthritis Clinic: Organizational Improvements in the Patient Journey. in Frontiers in medicine / Front Med (Lausanne). 2022 May 24;9:833139. doi: 10.3389/fmed.2022.833139. eCollection 2022.

2022
AO Ordine Mauriziano
AOU Città della Salute di Torino

Ferri S; Tirri E; Scarpa R; Selmi C; Sarzi Puttini P; Russo R; Padula AA; Pagano Mariano G; Lubrano E; Lomater C; Guggino G; Gremese E; Giacomelli R; Fusaro E; Franceschini F; Erre GL; D'Agostino MA; Dagna L; Ciccia F; Caminiti M; Baldissera E; Atzeni F; Afeltra A; D'Angelo S; Iannone F;

Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors: real-life data from the LORHEN registry. in International journal of rheumatic diseases / Int J Rheum Dis. 2018 Feb;21(2):422-430. doi: 10.1111/1756-185X.13199. Epub 2017 Oct 30.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pellerito R; Sarzi Puttini PC; Fusaro E; Atzeni F; Bazzani C; Grosso V; Gorla R; Becciolini A; Caporali R; Sinigaglia L; Favalli EG;

Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Sep-Oct;35(5):804-809. Epub 2017 Jul 27.

2017
AO Ordine Mauriziano
AOU Città della Salute di Torino

Pellerito R; Fusaro E; Bazzani C; Gorla R; Sarzi Puttini P; Atzeni F; Grosso V; Favalli EG; Caporali R; Manara M; Rocchetta PA; Sinigaglia L;